Table 4.
Obesity | Loss of touch sensation | Leg weakness | Hand weakness | Reduced exercise tolerance | ||||||
---|---|---|---|---|---|---|---|---|---|---|
| ||||||||||
OR | 95% CI | OR | 95% CI | OR | 95% CI | OR | 95% CI | OR | 95% CI | |
Tumor location | ||||||||||
Posterior fossa | 0.7 | 0.3–2.1 | 0.3 | 0.1–1.2 | 1.2 | 0.4–3.3 | 0.4 | 0.1–1.4 | 0.9 | 0.3–3.1 |
Supratentorial | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | |||||
Segmental radiation | ||||||||||
Posterior fossa/spine | ||||||||||
Yes | 0.2 | 0.1–1.1 | 2.3 | 0.3–20.1 | 1.2 | 0.2–6.9 | 2.3 | 0.2–23.0 | 1.1 | 0.1–8.4 |
None/scatter | 1.0 | 1.0 | 1.0 | 1.0 | ||||||
Temporal lobe | ||||||||||
Yes | 1.7 | 0.4–8.1 | 0.6 | 0.1–4.1 | 0.9 | 0.2–3.8 | 1.0 | 0.1–8.0 | 1.5 | 0.2–10.8 |
None/scatter | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | |||||
Frontal cortex | ||||||||||
Yes | 1.7 | 0.3–10.5 | 1.9 | 0.2–15.3 | 3.0 | 0.5–17.0 | 2.3 | 0.3–17.4 | 2.4 | 0.4–14.8 |
None/scatter | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | |||||
Occipital/parietal lobe | ||||||||||
Yes | 3.5 | 0.5–22.8 | 0.5 | 0.1–3.7 | 0.8 | 0.2–4.1 | 0.8 | 0.1–6.0 | 3.1 | 0.5–20.1 |
None/scatter | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | |||||
Received platinum or vincristine | ||||||||||
Yes | 0.2 | 0.1–1.1 | 1.6 | 0.3–7.1 | 3.8 | 0.8–17.8 | 1.2 | 0.3–5.6 | 0.8 | 0.2–3.3 |
No | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | |||||
Age at diagnosis | ||||||||||
< 5 years | 4.2 | 0.9–18.4 | 2.3 | 0.7–7.9 | 0.8 | 0.3–2.6 | 4.7* | 1.4–16.2 | 5.8* | 1.7–20.7 |
5–20 years | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 |
Estimates are statistically significant at p < 0.01